Computer-aided drug discovery has been around for decades, although the past few years
have seen a tectonic shift towards embracing computational technologies in both academia …

Now more than ever, traditional healthcare models are being overhauled with digital
technologies of Healthcare 4.0 increasingly adopted. Worldwide, digital devices are …

Recent research on artificial intelligence indicates that machine learning algorithms can
auto-generate novel drug-like molecules. Generative models have revolutionized de novo …

The current rise of artificial intelligence and machine learning has been significant. It has
reduced the human workload improved quality of life significantly. This article describes the …

Network pharmacology is an emerging area of systematic drug research that attempts to
understand drug actions and interactions with multiple targets. Network pharmacology has …

Artificial intelligence (AI) is becoming an integral part of drug discovery. It has the potential to
deliver across the drug discovery and development value chain, starting from target …

Digitalisation of the healthcare sector promises to revolutionise patient healthcare globally.
From the different technologies, virtual tools including artificial intelligence, blockchain …

Abstract Three-dimensional printing (3DP) is a transformative technology that is advancing
pharmaceutical research by producing personalized drug products. However, advances …

The factors determining a drug's success are manifold, making de novo drug design an
inherently multi-objective optimisation (MOO) problem. With the advent of machine learning …

Artificial intelligence (AI) is redefining how we exist in the world. In almost every sector of
society, AI is performing tasks with super-human speed and intellect; from the prediction of …